131 related articles for article (PubMed ID: 7450021)
1. [9-Nitro- and 9-amino-ellipticines and derivatives: synthesis and pharmacologic properties].
Gansser C; Viel C; Malvy C; Cros S
Farmaco Sci; 1980 Nov; 35(11):887-95. PubMed ID: 7450021
[TBL] [Abstract][Full Text] [Related]
2. [Syntheses designed to produce 8-amino ellipticine. Synthesis and pharmacological properties of 8-nitro ellipticine].
Gansser C; Lévque X; Plat M; Viel C
Farmaco Sci; 1982 May; 37(5):283-97. PubMed ID: 7095141
[TBL] [Abstract][Full Text] [Related]
3. Ellipticine, 9-hydroxyellipticine, and 9-hydroxyellipiticinum: some biochemical properties of possible pharmacologic significance.
Paoletti C; Auclair C; Lesca P; Tocanne JF; Malvy C; Pinto M
Cancer Treat Rep; 1981; 65 Suppl 3():107-18. PubMed ID: 7049365
[TBL] [Abstract][Full Text] [Related]
4. Mutagenicity and cytotoxicity of five antitumor ellipticines in mammalian cells and their structure-activity relationships in Salmonella.
DeMarini DM; Cros S; Paoletti C; Lecointe P; Hsie AW
Cancer Res; 1983 Aug; 43(8):3544-52. PubMed ID: 6344986
[TBL] [Abstract][Full Text] [Related]
5. Stereoselective synthesis of 9-hydroxyellipticine glycosides, novel and highly active antitumor agents.
Honda T; Inoue M; Kato M; Shima K; Shimamoto T
Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3975-8. PubMed ID: 3435996
[No Abstract] [Full Text] [Related]
6. Structure-activity relationships in a series of newly synthesized 1-amino-substituted ellipticine derivatives.
Ducrocq C; Wendling F; Tourbez-Perrin M; Rivalle C; Tambourin P; Pochon F; Bisagni E; Chermann JC
J Med Chem; 1980 Nov; 23(11):1212-6. PubMed ID: 7452670
[TBL] [Abstract][Full Text] [Related]
7. 1-Amino-substituted 4-methyl-5H-pyrido[4,3-b]indoles (gamma-carbolines) as tricyclic analogues of ellipticines: a new class of antineoplastic agents.
Bisagni E; Nguyen CH; Pierré A; Pépin O; de Cointet P; Gros P
J Med Chem; 1988 Feb; 31(2):398-405. PubMed ID: 3339609
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitumor activity of quaternary ellipticine glycosides, a series of novel and highly active antitumor agents.
Honda T; Kato M; Inoue M; Shimamoto T; Shima K; Nakanishi T; Yoshida T; Noguchi T
J Med Chem; 1988 Jul; 31(7):1295-305. PubMed ID: 3385725
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure, and cytostatic properties of new olivacine derivatives.
Jasztold-Howorko R; Croisy A; Carrez D; Jaroszewicz I; Nasulewicz A; Pełczyńska M; Opolski A
Arch Pharm (Weinheim); 2004 Nov; 337(11):599-604. PubMed ID: 15543533
[TBL] [Abstract][Full Text] [Related]
10. [Studies on the antineoplastic action of N-methylisoindigotin].
Ji XJ; Zhang FR; Liu Y; Gu QM
Yao Xue Xue Bao; 1985 Apr; 20(4):247-51. PubMed ID: 4072694
[No Abstract] [Full Text] [Related]
11. An alternative way of the synthesis of 1-substituted 9-methoxy-5-methyl-6H-pyrido[4,3-b]carbazole derivatives.
Jasztold-Howorko R; Croisy A; Carrez D
Acta Pol Pharm; 2005; 62(3):207-12. PubMed ID: 16193813
[TBL] [Abstract][Full Text] [Related]
12. [2 new antineoplastic derivatives: 9-hydroxy-2-methyl-ellipticinium (acetate) and 9-hydroxy-2,6-dimethyl-ellipticinium (chloride). Effect on mouse L 1210 leukemia].
Le Pecq JB; Gosse C; Nguyen-Dat-Xuong ; Paoletti C
C R Acad Hebd Seances Acad Sci D; 1975 Nov; 281(18):1365-7. PubMed ID: 815025
[TBL] [Abstract][Full Text] [Related]
13. Comparative cytotoxic and antitumoral effects of ellipticine derivatives on mouse L 1210 leukemia.
Paoletti C; Cros S; Xuong ND; Lecointe P; Moisand A
Chem Biol Interact; 1979 Apr; 25(1):45-58. PubMed ID: 466727
[TBL] [Abstract][Full Text] [Related]
14. Metabolism and disposition studies of 9-hydroxyellipticine and 2-methyl-9-hydroxyellipticinium acetate in animals.
Van-Bac N; Moisand C; Gouyette A; Muzard G; Dat-Xuong N; Le Pecq JB; Paoletti C
Cancer Treat Rep; 1980; 64(8-9):879-87. PubMed ID: 7448826
[TBL] [Abstract][Full Text] [Related]
15. Screening study on Taiwan plants for antitumor activities.
King ML; Wang CT; Chang CF; Hsu HM; Wang SJ; Hartwell JL; Abbott BJ
Cancer Chemother Rep 2; 1974 Jul; 4(3):1-96. PubMed ID: 4842546
[No Abstract] [Full Text] [Related]
16. N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines.
Ruckdeschel JC; Modi SP; el-Hamouly W; Portuese E; Archer S
J Med Chem; 1992 Dec; 35(26):4854-7. PubMed ID: 1479585
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity, pharmacology, and toxicity of ellipticines, ellipticinium, and 9-hydroxy derivatives: preliminary clinical trials of 2-methyl-9-hydroxy ellipticinium (NSC 264-137).
Paoletti C; Le Pecq JB; Dat-Xuong N; Juret P; Garnier H; Amiel JL; Rouesse J
Recent Results Cancer Res; 1980; 74():107-23. PubMed ID: 7003658
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of 4-amino-substituted 7-methoxy (and 7-hydroxy)- 11-methyl (and 5,11-dimethyl)-10H-pyrido [2,3-b] carbazoles and 4-amino- substituted 11-methyl (and 5,11-dimethyl)-10H-pyrido[3',4':4,5] pyrrolo [3,2-g] quinolines, two new series related to antitumor ellipticine derivatives.
Moron J; Rautureau M; Huel C; Pierré A; Berthier LK; Atassi G; Bisagni E
Anticancer Drug Des; 1993 Dec; 8(6):399-416. PubMed ID: 8286009
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effect of N alpha-benzyloxycarbonyl-N,N-bis-(2-halogenethyl)-hydrazide derivatives of amino acids.
Karaivanova MH; Zakhariev SG; Golovinsky EV
Neoplasma; 1980; 27(2):137-42. PubMed ID: 7393353
[TBL] [Abstract][Full Text] [Related]
20. Antitumoral activity of dipyrido [4,3-b] [3,4-f] indoles on L 1210 leukemia.
Lidereau R; Chermann JC; Gruest J; Montagnier L; Ducrocq C; Rivalle C; Bisagni E
Bull Cancer; 1980; 67(1):1-8. PubMed ID: 7362880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
